Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Courtagen and Avaxia join forces to create new assay

March 8, 2012

Tekmira Pharmaceuticals adds new RNAi therapeutic to pipeline

March 5, 2012

BioDelivery Sciences and FDA agree on BEMA-buprenorphine/naloxone development plan

Feb. 29, 2012

SGX-202 shows promise in model of gastrointestinal acute radiation syndrome

Feb. 22, 2012

Collaborating U.S. universities identify new monoamine reuptake inhibitors

Feb. 17, 2012

Titan Pharmaceuticals reports results from probuphine trial

Feb. 10, 2012

Study identifies mediator of drug-induced liver injury and agent to target it

Jan. 19, 2012

Inverseon announces initial indication for INV-102

Jan. 17, 2012

Herbal flavonoid counteracts alcohol intoxication

Jan. 17, 2012

New metabotropic glutamate mGlu5 receptor antagonists prepared by GlaxoSmithKline

Jan. 4, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
In the clinic for June 12, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Anixa, Beone, Bioinvent, Blossomhill, C4, Cellectis, Climb, Elixiron,...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...